← All trials
NCT00162058
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2004
- Primary completion
- Apr 30, 2006
- Completion date
- Apr 30, 2006
- First posted
- Sep 13, 2005
- Last posted
- Aug 18, 2011
- Enrollment
- 80
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Lantheus Medical ImagingLead sponsor
- Lantheus Medical ImagingSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.